tiprankstipranks
Quantum Healthcare Ltd. (SG:V8Y)
SGX:V8Y
Singapore Market
V8Y
Quantum Healthcare Ltd.
RESEARCH TOOLSreports

Quantum Healthcare Ltd. (V8Y) Ratios

1 Followers

Quantum Healthcare Ltd. Ratios

SG:V8Y's free cash flow for Q2 2025 was $0.45. For the 2025 fiscal year, SG:V8Y's free cash flow was decreased by $ and operating cash flow was $-0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.25 0.28 0.34 0.86
Quick Ratio
 0.24 0.28 0.34 0.86
Cash Ratio
 0.02 0.03 0.07 0.65
Solvency Ratio
 -0.01 -0.03 -0.14 -0.52
Operating Cash Flow Ratio
 0.11 0.13 -0.06 -0.17
Short-Term Operating Cash Flow Coverage
 0.49 0.56 -0.35 -0.99
Net Current Asset Value
$ -12.03M$ -12.30M$ -12.34M$ -8.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.59 0.61 0.50 0.52
Debt-to-Equity Ratio
 -1.73 -2.11 -1.68 -5.02
Debt-to-Capital Ratio
 2.37 1.90 2.46 1.25
Long-Term Debt-to-Capital Ratio
 -0.50 -0.97 -2.49 1.55
Financial Leverage Ratio
 -2.92 -3.46 -3.37 -9.60
Debt Service Coverage Ratio
 0.01 -0.12 -0.68 -4.18
Interest Coverage Ratio
 -3.35 -4.47 -5.70 -7.61
Debt to Market Cap
 0.50 0.28 0.31 0.14
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 80.22 -22.83 -3.98 -0.34
Profitability Margins
Gross Profit Margin
45.89%44.60%44.03%46.42%
EBIT Margin
-12.83%-16.25%-21.34%-88.92%
EBITDA Margin
0.85%-2.51%-11.08%-77.17%
Operating Profit Margin
-12.83%-16.22%-21.34%-36.50%
Pretax Profit Margin
-16.66%-19.87%-25.08%-93.71%
Net Profit Margin
-15.53%-17.61%-27.68%-96.78%
Continuous Operations Profit Margin
-17.12%-20.17%-25.85%-94.96%
Net Income Per EBT
93.24%88.62%110.36%103.27%
EBT Per EBIT
129.82%122.50%117.56%256.77%
Return on Assets (ROA)
-13.14%-17.84%-27.79%-62.76%
Return on Equity (ROE)
40.39%61.78%93.69%602.79%
Return on Capital Employed (ROCE)
1217.48%-188.81%-131.53%-51.73%
Return on Invested Capital (ROIC)
-34.49%-42.66%-56.35%-39.42%
Return on Tangible Assets
-22.73%-29.77%-53.53%-94.07%
Earnings Yield
-18.94%-14.06%-24.71%-22.38%
Efficiency Ratios
Receivables Turnover
 3.70 5.28 5.12 6.40
Payables Turnover
 9.88 6.10 7.64 4.39
Inventory Turnover
 85.29 149.53 197.86 156.84
Fixed Asset Turnover
 2.59 2.94 4.33 3.28
Asset Turnover
 0.85 1.01 1.00 0.65
Working Capital Turnover Ratio
 -1.16 -1.64 -3.17 -4.83
Cash Conversion Cycle
 66.02 11.65 25.40 -23.87
Days of Sales Outstanding
 98.67 69.09 71.32 57.00
Days of Inventory Outstanding
 4.28 2.44 1.84 2.33
Days of Payables Outstanding
 36.93 59.88 47.76 83.20
Operating Cycle
 102.95 71.53 73.16 59.33
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 <0.01 <0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.99 0.76 1.47 1.71
Dividend Paid and CapEx Coverage Ratio
 109.67 4.10 -2.11 -1.40
Capital Expenditure Coverage Ratio
 109.67 4.10 -2.11 -1.40
Operating Cash Flow Coverage Ratio
 0.19 0.19 -0.10 -0.17
Operating Cash Flow to Sales Ratio
 0.13 0.11 -0.05 -0.14
Free Cash Flow Yield
16.27%6.89%-6.32%-5.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.28 -7.11 -4.05 -4.47
Price-to-Sales (P/S) Ratio
 0.82 1.25 1.12 4.32
Price-to-Book (P/B) Ratio
 -2.02 -4.40 -3.79 -26.93
Price-to-Free Cash Flow (P/FCF) Ratio
 6.15 14.51 -15.82 -18.20
Price-to-Operating Cash Flow Ratio
 6.09 10.98 -23.33 -31.16
Price-to-Earnings Growth (PEG) Ratio
 -0.11 0.18 0.07 0.10
Price-to-Fair Value
 -2.02 -4.40 -3.79 -26.93
Enterprise Value Multiple
 176.78 -72.81 -14.09 -5.95
Enterprise Value
 14.67M 23.15M 20.42M 42.99M
EV to EBITDA
 176.78 -72.81 -14.09 -5.95
EV to Sales
 1.50 1.83 1.56 4.59
EV to Free Cash Flow
 11.25 21.14 -22.05 -19.31
EV to Operating Cash Flow
 11.15 15.99 -32.51 -33.07
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 -0.03 -0.02 -0.03 -0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 0.93 0.89 1.10 1.03
Interest Burden
 1.30 1.22 1.18 1.05
Research & Development to Revenue
 0.00 0.00 0.00 0.08
SG&A to Revenue
 0.50 0.54 0.67 0.71
Stock-Based Compensation to Revenue
 0.00 >-0.01 >-0.01 0.00
Income Quality
 -0.81 -0.57 0.19 0.15
Currency in USD